Notícias Senti Biosciences Inc - SNTI | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Senti Biosciences Inc (SNTI)
Senti Biosciences Inc (SNTI) Notícias

Senti Biosciences Inc (SNTI)

4,00

0,03

(0,76%)

Fechado 23 Dezembro 6:00PM

Atrasado por 15 minutos

4,00

0,00

( 0,00% )

Pré-mercado: 9:30AM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics

Senti Biosciences Announces New Employment Inducement Grants

Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity Financing

Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202, a Logic Gated, Selective CD33/FLT3-Targeting CAR-NK Cell Therapy for the Treatment of Relapsed/Refractory Hematologic Malignancies Including AML

Senti Bio Appoints Fran Schulz to Board of Directors

Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights

Senti Bio to Participate in Upcoming Investor Conferences

Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights

Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202

Senti Bio Announces Reverse Stock Split

Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Senti Biosciences

Investec Bnk 24

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições